Pharmacological heterogeneity of release-regulating presynaptic AMPA/kainate receptors in the rat brain: Study with receptor antagonists

Neurochemistry International

Volumn 42, Issue 4, 2003, Pages 283-292

  Ghersi, Chiara ^a   Bonfanti, Andrea ^a   Manzari, Benedetta ^a   Feligioni, Marco ^a   Raiteri, Maurizio ^a   Pittaluga, Anna ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

AMPA receptor subtypes; Central nervous system; Neurotransmitter release; Synaptosomes

Indexed keywords

1 (4 AMINOPHENYL) 3,4 DIHYDRO 4 METHYL 3 METHYLCARBAMOYL 7,8 METHYLENEDIOXY 5H 2,3 BENZODIAZEPINE; 1 (4 AMINOPHENYL) 4 METHYL 7,8 METHYLENE DIOXY 5H 2,3 BENZODIAZEPINE; 2 AMINO 3 [3 (CARBOXYMETHYOXY) 5 METHYL ISOXAZOL 4 YL] PROPIONIC ACID; 4 (4 AMINOPHENYL) 1,2 DIHYDRO 1 METHYL 2 PROPYLCARBAMOYL 6,7 METHYLENEDIOXYPHTHALAZINE; 6 [[[(1H TETRAZOL 5 YL)METHYL]OXY]METHYL] 1,2,3,4,4A,5,6,7,8,8A DECA HYDROXYISOQUINOLINE 3 CARBOXYLIC ACID; 6 NITRO 7 SULFAMOYLBENZO[F]QUINOXALINE 2,3 DIONE; 6,7,8,9 TETRAHYDRO 5 NITROBENZ[G]INDOLE 2,3 DIONE 3 OXIME; ACETYLCHOLINE; ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; AMPA RECEPTOR; AMPA RECEPTOR ANTAGONIST; DOPAMINE; GAMMA DEXTRO GLUTAMYLAMINOMETHYLSULFONIC ACID; GAMMA DEXTRO GLUTAMYLGLYCINE; GYK 152466; KAINIC ACID RECEPTOR; KAINIC ACID RECEPTOR AGONIST; LY 377770; NEUROTRANSMITTER; NORADRENALIN; SEROTONIN; SYM 2206; TALAMPANEL; TRITIUM; UNCLASSIFIED DRUG;

ACETYLCHOLINE RELEASE; ANIMAL TISSUE; ARTICLE; BRAIN SYNAPTOSOME; CONTROLLED STUDY; DOPAMINE RELEASE; DRUG ANTAGONISM; DRUG EFFECT; DRUG MECHANISM; DRUG POTENCY; DRUG SELECTIVITY; MALE; MOLECULAR MIMICRY; NONHUMAN; NORADRENALIN RELEASE; PRIORITY JOURNAL; RAT; SEROTONIN RELEASE;

ACETYLCHOLINE; ANIMALS; BRAIN CHEMISTRY; DOPAMINE; EXCITATORY AMINO ACID ANTAGONISTS; MALE; NOREPINEPHRINE; PRESYNAPTIC TERMINALS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, AMPA; RECEPTORS, KAINIC ACID; RECEPTORS, PRESYNAPTIC; SEROTONIN; SYNAPTIC TRANSMISSION; SYNAPTOSOMES;

EID: 0037333066     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-0186(02)00129-8     Document Type: Article

References (46)

1. Bettler B., Mulle C. Review: neurotransmitter receptors II AMPA and kainate receptors. Neuropharmacology. 34:1995;123-139.
2. Bi X., Standley S., Baudry M. Posttranslational regulation of ionotropic glutamate receptors and synaptic plasticity. Int. Rev. Neurobiol. 42:1998;227-284.
3. Bleakman D., Lodge D. Neuropharmacology of AMPA and kainate receptors. Neuropharmacology. 37:1998;1187-1204.
4. Bleakman D., Ballyk B.A., Schoepp D.D., Palmer A.J., Bath C.P., Sharpe E.F., Woolley M.L., Bufton H.R., Kamboj R.K., Tarnawa I., Lodge D. Activity of 2,3-benzodiazepines at native rat and recombinant human glutamate receptors. Neuropharmacology. 35:1996;1689-1702.
5. Chittajallu R., Braithwaite S.P., Clarke V.R.J., Henley J.M. Kainate receptors: subunits, synaptic localization and function. Trends Pharmacol. Sci. 20:1999;26-35.
6. Clarke V.R.J., Ballyk B.A., Hoo K.H., Mandelzys A., Pellizzari A., Bath C.P., Thomas J., Sharpe E.F., Davies C.H., Ornstein P.L., Schoepp D.D., Kamboj R.K., Collingridge G.L., Lodge D., Bleakman D. A hippocampal GluR5 kainate receptor regulating inhibitory synaptic transmission. Nature. 389:1997;599-603.
7. 3H ]norepinephrine release from rat hippocampal slices J. Neurochem. 63:1994;231-237.
8. Desai M.A., Burnett J.P., Ornstein P.L., Schoepp D.D. Cyclothiazide acts at a site on the α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor complex that does not recognize competitive or noncompetitive AMPA receptor antagonists. J. Pharmacol. Exp. Ther. 272:1995;38-43.
9. Desce J.M., Godeheu G., Galli T., Artaud F., Chéramy A., Glowinski J. Presynaptic facilitation of dopamine release through D, L-α-amino-3-hydroxy-5-methyl-4-isoxazole propionate receptors on synaptosomes from the rat striatum. J. Pharmacol. Exp. Ther. 259:1991;692-698.
10. Donevan S.D., Rogawski M.A. GYKI52466, a 2,3-benzodiazepine, is a highly selective, noncompetitive antagonist of AMPA/kainate receptor responses. Neuron. 10:1993;51-59.
11. Donevan S.D., Rogawski M.A. Allosteric regulation of α-amino-3-hydroxy-5-methyl-4-isoxazole-propionate receptors by thiocyanate and cyclothiazide at a common modulatory site distinct from that of 2,3-benzodiazepines. Neuroscience. 87:1998;615-629.
12. Fletcher E.J., Martin D., Aram J.A., Lodge D., Honoré T. Quinoxalinediones selectively block quisqualate and kainate receptors and synaptic events in rat neocortex and hippocampus and frog spinal cord in vitro. Br. J. Pharmacol. 95:1988;585-597.
13. Frandsen A., Krogsgaard-Larsen P., Schousboe A. Novel glutamate receptor antagonists selectively protect against kainic acid induced neurotoxicity in cultured cerebral cortex neurones. J. Neurochem. 55:1990;1821-1823.
14. Gill R., Lodge D. The neuroprotective effects of the decahydroisoquinoline, LY 215490 a novel AMPA antagonist in focal ischaemia. Neuropharmacology. 33:1994;1529-1536.
15. Gold S.J., Ambros-Ingerson J., Horowitz J.-R., Lynch G., Gall C.M. Stoichiometries of AMPA receptor subunit mRNAs in rat brain fall into discrete categories. J. Comp. Neurol. 385:1997;491-502.
16. 3H ]GABA release in rat striatum Neurochem. Int. 37:2000;33-45.
17. Hollmann M., Heinemann S. Cloned glutamate receptors. Annu. Rev. Neurosci. 17:1994;31-108.
18. Honoré T., Drejer J. Chaotropic ions affect the conformation of quisqualate receptors in rat cortical membranes. J. Neurochem. 51:1988;457-461.
19. Jin S. AMPA-and kainate-receptors differentially mediate excitatory amino acid-induced dopamine and acetylcholine release from rat striatal slices. Neuropharmacology. 36:1997;1503-1510.
20. Kapus G., Bódi I., Pataki Á., Gueritaud J.-P., Székely J.I., Tarnawa I. Differential modulation of the GYKI53784-induced inhibition of AMPA currents by various AMPA-positive modulators in cerebellar Purkinje cells. Eur. J. Pharmacol. 397:2000;43-47.
21. Krogsgaard-Larsen P., Ferkany J.W., Nielsen E.Ø., Madsen U., Ebert B., Johansen J.S., Diemer N.H., Bruhn T., Beattie D.T., Curtis D.R. Novel class of amino acid antagonists at non-N-methyl-D-aspartic acid excitatory amino acid receptors. Synthesis, in vitro and in vivo pharmacology and neuroprotection. J. Med. Chem. 34:1991;123-130.
22. Lerma J., Paternain A.V., Naranjo J.R., Mellström B. Functional kainate-selective glutamate receptors in cultured hippocampal neurons. Proc. Natl. Acad. Sci. U.S.A. 90:1993;11688-11692.
23. Lerma J., Paternain A.V., Rodríguez-Moreno A., López-García J.C. Molecular physiology of kainate receptors. Physiol. Rev. 81:2001;971-998.
24. O'Neill M.J., Bogaert L., Hicks C.A., Bond A., Ward M.A., Ebinger G., Ornstein P.L., Michotte Y., Lodge D. LY377770, a novel iGlu5 kainate receptor antagonist with neuroprotective effects in global and focal cerebral ischemia. Neuropharmacology. 39:2000;1575-1588.
25. Partin K.M., Mayer M.L. Negative allosteric modulation of wild-type and mutant AMPA receptors by GYKI53655. Mol. Pharmacol. 49:1996;142-148.
26. Partin K.M., Patneau D.K., Winters C.A., Mayer M.L., Buonanno A. Selective modulation of desensitization at AMPA receptors vs. kainate receptors by cyclothiazide and concanavalin A. Neuron. 11:1993;1069-1082.
27. Pearce P.C., Maclean C.J., Shergill H.K., Ward E.M., Halsey M.J., Tindley G., Pearson J., Meldrum B.S. Protection from high pressure induced hyperexcitability by the AMPA/kainate receptor antagonists GYKI52466 and LY293558. Neuropharmacology. 33:1994;605-612.
28. Pelletier J.C., Hesson D.P., Jones K.A., Costa A.-M. Substituted 1,2-dihydrophthalazines: potent, selective, and noncompetitive inhibitors of the AMPA receptor. J. Med. Chem. 39:1996;343-346.
29. 3H ]dopamine release from rat mesencephalic cells in primary culture J. Neurochem. 64:1995;1410-1412.
30. Pittaluga A., Raiteri M. N-Methyl-D-aspartic acid (NMDA) and non-NMDA receptors regulating hippocampal norepinephrine release. I. Location on axon terminals and pharmacological characterization. J. Pharmacol. Exp. Ther. 260:1992;232-237.
31. Pittaluga A., Thellung S., Maura G., Raiteri M. Characterization of two central AMPA-preferring receptors having distinct location, function and pharmacology. Naunyn-Schmiedeb. Arch. Pharmacol. 349:1994;555-558.
32. Pittaluga A., Bonfanti A., Raiteri M. Differential desensitization of ionotropic non-NMDA receptors having distinct neuronal location and function. Naunyn-Schmiedeb. Arch. Pharmacol. 356:1997;29-38.
33. Raiteri L., Raiteri M. Synaptosomes still viable after 25 years of superfusion. Neurochem. Res. 25:2000;1265-1274.
34. Raiteri M., Angelini F., Levi G. A simple apparatus for studying the release of neurotransmitters from synaptosomes. Eur. J. Pharmacol. 25:1974;411-414.
35. Raiteri, M., Marchi, M., Maura, G., 1984. Release of catecholamines, serotonin and acetylcholine from isolated brain tissue. In: Lajtha, A. (Ed.), Handbook of Neurochemistry, Vol. 6. Plenum Press, New York, pp. 431-462.
36. Rakovska A., Kiss J.P., Raichev P., Lazarova M., Kalfin R., Djambazova E. The non-competitive AMPA receptor antagonist (GYKI52466) blocks quisqualate-induced acetylcholine release from the rat hippocampus and striatum: an in vivo microdialysis study. Neurochem. Int. 40:2002;419-426.
37. Rammes G., Swandulla D., Spielmanns P., Parsons C.G. Interactions of GYKI52466 and NBQX with cyclothiazide at AMPA receptors: experiments with outside-out patches and EPSCs in hippocampal neurones. Neuropharmacology. 37:1998;1299-1320.
38. Schoepp D.D., Lodge D., Bleakman D., Leander J.D., Tizzano J.P., Wright R.A., Palmer A.J., Salhoff C.R., Ornstein P.L. In vitro and in vivo antagonism of AMPA receptor activation by (3S, 4aR, 6R, 8aR)-6-[2-(1(2)H-tetrazole-5-yl) ethyl] decahydroisoquinoline-3-carboxylic acid. Neuropharmacology. 34:1995;1159-1168.
39. Sheardown M.J., Nielsen E.O., Hansen A.J., Jacobsen P., Honoré T. 2,3-Dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline: a neuroprotectant for cerebral ischemia. Science. 247:1990;571-574.
40. Tao R., Ma Z., Auerbach S.B. Influence of AMPA/kainate receptors on extracellular 5-hydroxytryptamine in rat midbrain raphe and forebrain. Br. J. Pharmacol. 121:1997;1707-1715.
41. Verdoorn T.A., Johansen T.H., Drejer J., Nielsen E.O. Selective block of recombinant GluR6 receptors by NS-102, a novel non-NMDA receptor antagonist. Eur. J. Pharmacol. 269:1994;43-49.
42. Vizi E.S., Mike A., Tarnawa I. 2,3-Benzodiazepines (GYKI52466 and analogs): negative allosteric modulators of AMPA receptors. CNS Drug Rev. 2:1996;91-126.
43. Wahl P., Nielsen B., Krogsgaard-Larsen P., Hansen J.J., Schousboe A., Miledi R. Stereoselective effects of AMOA on non-NMDA receptors expressed in Xenopus oocytes. J. Neurosci. Res. 33:1992;392-397.
44. Wahl P., Frandsen A., Madsen U., Schousboe A., Krogsgaard-Larsen P. Pharmacology and toxicology of ATOA, an AMPA receptor antagonist and a partial agonist at GluR5 receptors. Neuropharmacology. 37:1998;1205-1210.
45. Watkins J.C., Evans R.H. Excitatory amino acid transmitters. Annu. Rev. Pharmacol. Toxicol. 21:1981;165-204.
46. Wilding T.J., Huettner J.E. Antagonist pharmacology of kainate and alpha amino-3-hydroxy-5-methyl-4-isoxazole propionic acid preferring receptors. Mol. Pharmacol. 49:1996;540-546.